| Estrogen replacement reduces risk and increases survival times of women with hepatocellular carcinoma MM Hassan, G Botrus, R Abdel-Wahab, RA Wolff, D Li, D Tweardy, ... Clinical Gastroenterology and Hepatology 15 (11), 1791-1799, 2017 | 93 | 2017 |
| Evaluating clinical and prognostic implications of Glypican-3 in hepatocellular carcinoma AO Kaseb, M Hassan, S Lacin, R Abdel-Wahab, HM Amin, A Shalaby, ... Oncotarget 7 (43), 69916, 2016 | 48 | 2016 |
| Analysis of Fusobacterium nucleatum and Streptococcus gallolyticus in saliva of colorectal cancer patients DC Guven, O Dizdar, A Alp, FN Akdoğan Kittana, D Karakoc, ... Biomarkers in Medicine 13 (9), 725-735, 2019 | 31 | 2019 |
| Recent advances in the management of pancreatic adenocarcinoma Y Karakas, S Lacin, S Yalcin Expert review of anticancer therapy 18 (1), 51-62, 2018 | 28 | 2018 |
| Acute pancreatitis associated with H1N1 influenza during 2009 pandemic: a case report B Baran, C Karaca, OM Soyer, S Lacin, K Demir, F Besisik, G Boztas Clinics and research in hepatology and gastroenterology 36 (4), e69-e70, 2012 | 23 | 2012 |
| The prognostic value of circulating VEGF-A level in patients with hepatocellular cancer S Lacin, S Yalcin Technology in Cancer Research & Treatment 19, 1533033820971677, 2020 | 20 | 2020 |
| Metastatic medullary thyroid cancer: a dramatic response to a systemic chemotherapy (temozolomide and capecitabine) regimen S Lacin, E Esin, Y Karakas, S Yalcin OncoTargets and therapy, 1039-1042, 2015 | 17 | 2015 |
| The comparison of FOLFOX regimens with different doses of 5-FU for the adjuvant treatment of colorectal cancer: a multicenter study N Akdeniz, MA Kaplan, D Uncu, M İnanç, S Kaya, F Dane, M Küçüköner, ... International Journal of Colorectal Disease 36, 1311-1319, 2021 | 16 | 2021 |
| Does systemic anti-tumor therapy increase COVID-19 risk in patients with cancer? M Ayhan, Ş Laçin, DT Özyükseler, H Sürmeli, A Doğan, M Turan, ... Journal of Oncology Pharmacy Practice 27 (6), 1461-1467, 2021 | 11 | 2021 |
| Easier and more explanatory indices by integrating leukocyte lymphocyte ratio (LLR) and prognostic nutritional index (PNI) to IPS systems in cases with classical Hodgkin lymphoma S Paydas, S Lacin, M Dogan, I Barista, B Yildiz, G Seydaoglu, ... Leukemia Research 107, 106586, 2021 | 10 | 2021 |
| Nonalcoholic steatohepatitis-related hepatocellular carcinoma: is there a role for the androgen receptor pathway? MA Ali, S Lacin, R Abdel-Wahab, M Uemura, M Hassan, A Rashid, ... OncoTargets and therapy, 1403-1412, 2017 | 10 | 2017 |
| Impact of integrating insulin-like growth factor 1 levels into model for end-stage liver disease score for survival prediction in hepatocellular carcinoma patients R Abdel-Wahab, MM Hassan, B George, R Carmagnani Pestana, L Xiao, ... Oncology 98 (12), 836-846, 2020 | 9 | 2020 |
| Protective effects of taxifolin on pazopanib-induced liver toxicity: an experimental rat model B Akagunduz, M Ozer, F Ozcıcek, AV Kara, S LAcın, M Özkaraca, ... Experimental animals 70 (2), 169-176, 2021 | 8 | 2021 |
| Comparison of prognosis and clinical features between synchronous bilateral and unilateral breast cancers Y Karakas, N Kertmen, S Lacin, A Aslan, M Demir, O Ates, S Aksoy, ... Age 24, 0.63, 2017 | 7 | 2017 |
| A case of acanthosis nigricans as a paraneoplastic syndrome with squamous cell lung cancer Y Karakas, E Esin, S Lacin, K Ceyhan, AO Heper, S Yalcin OncoTargets and therapy, 4815-4820, 2016 | 7 | 2016 |
| Immunosuppressive tumor microenvironment contributes to tumor progression in diffuse large B-cell lymphoma upon anti-CD19 chimeric antigen receptor T therapy Z Yan, L Li, D Fu, W Wu, N Qiao, Y Huang, L Jiang, D Wu, Y Hu, H Zhang, ... Frontiers of Medicine 17 (4), 699-713, 2023 | 6 | 2023 |
| The effect of exercise on disease-free survival and overall survival in patients with breast cancer N Akdeniz, MA Kaplan, M Küçüköner, Z Urakçı, Ş Laçin, EH Ceylan, ... Irish Journal of Medical Science (1971-), 1-11, 2021 | 6 | 2021 |
| Correlation of educational status and clinicopathological characteristics of breast cancer: A single center experience F Sarici, T Babacan, H Buyukhatipoglu, O Balakan, AR Sever, N Kertmen, ... breast cancer 6 (13), 14, 2016 | 6 | 2016 |
| The Effect of Metabolic PET Parameters on Survival Outcome in Malignant Pleural Mesothelioma N Akdeniz, M Küçüköner, MA Kaplan, Z URAKÇI, O Karhan, H Yerlikaya, ... Dicle Tıp Dergisi 47 (1), 16-23, 2020 | 5 | 2020 |
| Metastatic ameloblastoma to the liver: rare presentation of a rare disease S Lacin, A Dogrul, E Dikmen, N Kertmen, A Turker, A Kars J Clin Case Rep 9 (1207), 2, 2019 | 5 | 2019 |
